.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Fuji
Fish and Richardson
Farmers Insurance
Johnson and Johnson
Cipla
Julphar
AstraZeneca
Federal Trade Commission
Teva

Generated: June 25, 2017

DrugPatentWatch Database Preview

RANITIDINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Ranitidine Hydrochloride, and what generic Ranitidine Hydrochloride alternatives are available?

Ranitidine Hydrochloride is a drug marketed by Ranbaxy, Wockhardt, Apotex Inc, Bio Pharm Inc, Pharm Assoc, Dr Reddys Labs Inc, Amneal Pharms, Strides Pharma, Watson Labs, Sandoz, Aurobindo Pharma Ltd, Mylan, Actavis Mid Atlantic, Amneal Pharms Ny, Watson Labs Inc, Perrigo R And D, Sun Pharm Inds Ltd, Zydus Pharms Usa Inc, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Tolmar, Teva, West-ward Pharms Int, Boehringer Ingelheim, Bedford, Ivax Sub Teva Pharms, Mylan Labs Ltd, Taro, Hi Tech Pharma, Apotex, Par Pharm, Breckenridge Pharm, Silarx, Vintage Pharms, Nostrum Labs Inc, Contract Pharmacal, and Perrigo. and is included in sixty-one NDAs.

The generic ingredient in RANITIDINE HYDROCHLORIDE is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. One hundred and forty-one suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ranitidine hydrochloride profile page.

Summary for Tradename: RANITIDINE HYDROCHLORIDE

Patents:0
Applicants:37
NDAs:61
Suppliers / Packagers: see list133
Bulk Api Vendors: see list83
Clinical Trials: see list2,325
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RANITIDINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: RANITIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge Pharm
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
SYRUP;ORAL078684-001Aug 27, 2009AARXNoNo► Subscribe► Subscribe
Mylan
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
TABLET;ORAL074552-002Jul 30, 1998DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
TABLET;ORAL075439-001Apr 19, 2000DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
INJECTABLE;INJECTION077458-001Feb 16, 2006APRXNoNo► Subscribe► Subscribe
Apotex Inc
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
TABLET;ORAL075167-001May 4, 2000OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Queensland Health
McKesson
Deloitte
Fuji
Moodys
Farmers Insurance
Covington
Healthtrust
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot